(PHILADELPHIA) – Combining natural organic atoms with metal complexes, scientists at The Wistar Institute have developed a new type of enzyme inhibitor capable of blocking a biochemical pathway that ...
Molecular Tumor Board–Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial The development of the selective RET inhibitors selpercatinib and pralsetinib has ...
The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback